Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations

Author:

Lyskjær Iben12ORCID,Davies Christopher13,Strobl Anna‐Christina13,Hindley Joanna3,James Steven4,Lalam Radhesh K.5,Cross William1,Hide Geoff6,Rankin Kenneth S.67,Jeys Lee8,Tirabosco Roberto3,Stevenson Jonathan9,O’Donnell Paul15,Cool Paul1011,Flanagan Adrienne M.13,

Affiliation:

1. Research Department of Pathology University College London UCL Cancer Institute London UK

2. Medical Genomics Research Group University College London UCL Cancer Institute London UK

3. Department of Histopathology Royal National Orthopaedic Hospital Stanmore UK

4. Department of Musculoskeletal Imaging Royal Orthopaedic Hospital Birmingham UK

5. Department of Radiology Royal National Orthopaedic Hospital Stanmore UK

6. North of England Bone and Soft Tissue Tumour Service Freeman Hospital Newcastle UK

7. Newcastle Centre for Cancer Newcastle University UK

8. Orthopaedic Department Royal Orthopaedic Hospital NHS Foundation Trust Birmingham UK

9. Department of Orthopaedic Oncology and Arthroplasty Royal Orthopaedic Hospital NHS Foundation Trust Birmingham UK

10. Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust Oswestry UK

11. Keele University UK

Funder

UCLH Biomedical Research Centre

Lundbeckfonden

National Institute for Health Research

Bone Cancer Research Trust

Sarcoma UK

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3